A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2011
11/02/2011	CN102228534A Method for extracting flavone from hawthorn berry
11/02/2011	CN102228533A Application of apple polyphenol to preparation of medicaments or food for reducing blood sugar
11/02/2011	CN102228521A New Chinese medicine for treating early and middle-stage diabetic nephropathy
11/02/2011	CN102228517A Plantain seed extract and application thereof
11/02/2011	CN102228515A Separation and enrichment method of total flavones and total alkaloids of Lotus Plumule
11/02/2011	CN102228513A Medicinal composition for treating diabetes or diabetic complications and preparation method thereof
11/02/2011	CN102228507A Method for extracting engelhardtia roxburghiana extract and engelhardtia roxburghiana extract capsules thereof
11/02/2011	CN102228500A Method for producing Euonymus hederaceus Champ. ex Benth preparation and application thereof
11/02/2011	CN102228484A Chinese medicinal preparation Jinshuibao oral liquid and preparation method thereof
11/02/2011	CN102228457A Pharmaceutical composition for treating diabetes and complication thereof
11/02/2011	CN102228452A Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof
11/02/2011	CN102228447A Zinc-selenium chewable tablet
11/02/2011	CN102228444A N(2)-L-alanyl-L-glutamine preparation for injection and preparation method thereof
11/02/2011	CN102228436A Slow-release liquid crystal nanoparticle containing vinpocetine prepared by supercritical fluid method
11/02/2011	CN102228435A Water-soluble vitamin liposome pharmaceutical composition formula and preparation method and application thereof
11/02/2011	CN102228428A Large volume injection composition containing vinpocetine and preparation method thereof
11/02/2011	CN102228423A Tolvaptan oral solid medicinal composition and preparation method thereof
11/02/2011	CN102228179A Fructose sodium diphosphate oral solution and preparation method thereof
11/02/2011	CN102228111A Health-care tea capable of assisting diabetes treatment and preparation method thereof
11/02/2011	CN101912470B Chinese medicinal powder for treating diabetes
11/02/2011	CN101904971B Chinese medicinal composition for preventing and treating obesity and preparation thereof
11/02/2011	CN101864375B Lactobacillu plantarurn with function of reducing cholesterol and application thereof
11/02/2011	CN101862346B Hypoglycemic application of gingseng acidic polysaccharide
11/02/2011	CN101703577B Preparation method of guava leaf extract and traditional Chinese medicine preparation thereof
11/02/2011	CN101080411B Thiazolopyridinone derivates as MCH receptor antagonists
11/02/2011	CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048901 5-{3-[3-(5-Methyl-2-m-tolyloxazol-4-ylmethoxy)cyclohexyloxy]-propyl}-2H-tetrazole; metabolic disorders, insulin resistance, dyslipidemia, Syndrome X
11/01/2011	US8048897 Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
11/01/2011	US8048873 Synergistic pharmaceutical combination for the prevention or treatment of diabetes
11/01/2011	US8048866 Preventive and/or therapeutic agent for calcipenia
11/01/2011	US8048452 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor
11/01/2011	CA2695167C Methods for the treatment of elevated cholesterol levels
11/01/2011	CA2641473C Condensed imidazole derivatives as aldosterone synthase inhibitors
11/01/2011	CA2545644C Melanocortin receptor agonists
11/01/2011	CA2535749C Ppar activating compound and pharmaceutical composition containing same
11/01/2011	CA2521621C Compounds for the treatment of metabolic disorders
11/01/2011	CA2521589C Compounds for the treatment of metabolic disorders
11/01/2011	CA2513092C Compounds for the treatment of metabolic disorders
11/01/2011	CA2490277C Use of vasopeptidase inhibitors in the treatment of nephropathy
11/01/2011	CA2490254C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
11/01/2011	CA2488834C Purine derivatives and their use as antiproliferative agents
11/01/2011	CA2476683C Partial and full agonists of a1 adenosine receptors
11/01/2011	CA2473591C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011	CA2395459C Use of quinoline and quinolizinone derivatives as chemotherapeutic agents
10/2011
10/27/2011	WO2011133795A2 Beta-carbolines as inhibitors of haspin and dyrk kinases
10/27/2011	WO2011133750A1 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011	WO2011133434A1 Methods of treating glucose metabolism disorders
10/27/2011	WO2011133204A1 Methods and assays for treating or preventing obesity and/or diabetes or increasing insulin sensitivity
10/27/2011	WO2011133182A1 Modulators of 5-ht receptors and methods of use thereof
10/27/2011	WO2011132692A1 Visceral fat accumulation inhibitor
10/27/2011	WO2011132172A1 NOVEL INTERMEDIATES FOR THE PREPARATION OF HMG-CoA REDUCTASE INHIBITORS
10/27/2011	WO2011131976A1 Comestible product
10/27/2011	WO2011131707A1 ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES
10/27/2011	WO2011131613A1 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
10/27/2011	WO2011131605A1 Production of atorvastatin low in ether impurities
10/27/2011	WO2011131593A1 Derivatives of nitrogen heterocycles, method for preparing same and use thereof in human therapy
10/27/2011	WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof
10/27/2011	WO2011089529A4 Salicylate fatty acid derivatives
10/27/2011	WO2011087713A3 Substituted hexahydrochromeno [3, 4 - b] pyrroles with affinity for the serotonin receptor (5-ht) family
10/27/2011	WO2011083998A3 Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
10/27/2011	WO2011081915A3 Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
10/27/2011	US20110263720 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same
10/27/2011	US20110263718 Process for the preparation of o-desmethylvenlafaxine
10/27/2011	US20110263704 Methods of Using Cycloalkylmethylamines
10/27/2011	US20110263702 Methods and Compositions for Improved Chromium Complexes
10/27/2011	US20110263687 Rna molecules and uses thereof
10/27/2011	US20110263681 Organic Compositions to Treat Beta-ENaC-Related Diseases
10/27/2011	US20110263673 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives
10/27/2011	US20110263669 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors
10/27/2011	US20110263668 Beta 3-Adrenoreceptor Agonists for the Treatment of Cardiac Hypertrophy and Heart Failure
10/27/2011	US20110263662 1,2-diamido-ethylene derivatives as orexin antagonists
10/27/2011	US20110263659 Analogs of 1-Methylnicotinamide
10/27/2011	US20110263658 Renin inhibitors
10/27/2011	US20110263656 Pirfenidone Treatment for Patients with Atypical Liver Function
10/27/2011	US20110263654 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
10/27/2011	US20110263651 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011	US20110263629 Amides of diazabicyclooctanes and uses thereof
10/27/2011	US20110263624 Bicyclic heterocycle derivatives and methods of use thereof
10/27/2011	US20110263619 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
10/27/2011	US20110263617 Combination therapy for the treatment of diabetes and related conditions
10/27/2011	US20110263605 Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
10/27/2011	US20110263600 Method for preventing or treating a disease related to the glucocorticoid receptor
10/27/2011	US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011	US20110263593 NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS
10/27/2011	US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011	US20110263587 Reversibly heat-gelable aqueous composition
10/27/2011	US20110263583 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
10/27/2011	US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011	US20110263577 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
10/27/2011	US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011	US20110263570 Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
10/27/2011	US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011	US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011	US20110263562 Bicyclic compound
10/27/2011	US20110263561 Novel pyrrolidone derivatives for use as MetAP-2 inhibitors
10/27/2011	US20110263559 Indazole compounds useful as ketohexokinase inhibitors

1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 1298